Biggest changeFINANCIAL STATEMENTS CONSOLIDATED BALANCE SHEETS (In thousands) March 31, March 31, 2024 2023 ASSETS Current assets: Cash and cash equivalents $ 90,522 $ 23,360 Accounts receivable, net 26,325 30,665 Inventory, net 41,857 36,986 Prepaid expenses and other current assets 7,295 13,429 Restricted cash 468 1,733 Total current assets 166,467 106,173 Property, plant and equipment, net 10,861 12,309 Intangibles, net 6,369 8,527 Right-of-use assets 2,557 2,857 Goodwill 43,471 43,471 Restricted cash 1,290 582 Deferred tax assets 1,119 1,114 Other assets 637 528 Total assets $ 232,771 $ 175,561 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 24,235 $ 38,383 Lease liability, current portion 716 808 Debt, current portion 25 75 Contingent consideration 3,100 1,270 Deferred revenue, current portion 50,732 43,572 Total current liabilities 78,808 84,108 Deferred revenue, long term portion 7,097 7,188 Lease liability, long term portion 1,968 2,184 Deferred tax liabilities 300 243 Debt, long-term portion — 15 Other liabilities 27 26 Total liabilities 88,200 93,764 Commitments and Contingencies (Note 17) Stockholders' equity: Common stock, $ 0.01 par value, 75,000,000 shares authorized; 37,343,812 and 29,937,119 shares issued and 36,946,181 and 29,539,488 shares outstanding at March 31, 2024 and 2023, respectively 373 299 Additional paid-in capital 1,212,913 1,139,113 Treasury stock, at cost, 397,631 at March 31, 2024 and 2023, respectively (3,639 ) (3,639 ) Accumulated other comprehensive income 1,582 1,571 Accumulated deficit (1,066,658 ) (1,055,547 ) Total stockholders' equity 144,571 81,797 Total liabilities and stockholders' equity $ 232,771 $ 175,561 The accompanying notes are an integral part of the consolidated financial statements. 35 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) Fiscal Year Ended March 31, 2024 2023 Revenues $ 145,639 $ 105,984 Cost of revenues 110,356 97,463 Gross profit 35,283 8,521 Operating expenses: Research and development 7,991 8,966 Selling, general and administrative 31,600 28,700 Amortization of acquisition related intangibles 2,152 2,746 Change in fair value on contingent consideration 4,922 70 Restructuring (14 ) 1,048 Total operating expenses 46,651 41,530 Operating loss (11,368 ) (33,009 ) Interest income, net 1,302 252 China dissolution — (1,921 ) Other expense, net (736 ) (148 ) Loss before income tax expense (10,802 ) (34,826 ) Income tax expense 309 215 Net loss $ (11,111 ) $ (35,041 ) Net loss per common share Basic $ (0.37 ) $ (1.26 ) Diluted $ (0.37 ) $ (1.26 ) Weighted average number of common shares outstanding Basic 29,825 27,848 Diluted 29,825 27,848 The accompanying notes are an integral part of the consolidated financial statements. 36 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (In thousands) Fiscal Year Ended March 31, 2024 2023 Net loss $ (11,111 ) $ (35,041 ) Other comprehensive income, net of tax: China dissolution — 1,921 Foreign currency translation gain (loss) 11 (59 ) Total other comprehensive income, net of tax 11 1,862 Comprehensive loss $ (11,100 ) $ (33,179 ) The accompanying notes are an integral part of the consolidated financial statements. 37 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (In thousands) Common Stock Accumulated Other Total Number of Shares Par Value Additional Paid-in Capital Treasury Stock Comprehensive Income (Loss) Accumulated Deficit Stockholders' Equity Balance at March 31, 2022 28,920 $ 289 $ 1,133,536 $ (3,639 ) $ (291 ) $ (1,020,506 ) $ 109,389 Issuance of common stock - ESPP 60 1 234 — — — 235 Issuance of common stock - restricted shares, net of forfeited shares 827 8 (8 ) — — — — Stock-based compensation expense — — 4,729 — — — 4,729 Issuance of stock for 401(k) match 130 1 622 — — — 623 Cumulative translation adjustment — — — — 1,862 — 1,862 Net loss — — — — — (35,041 ) (35,041 ) Balance at March 31, 2023 29,937 $ 299 $ 1,139,113 $ (3,639 ) $ 1,571 $ (1,055,547 ) $ 81,797 Issuance of common stock - ESPP 34 — 279 — — — 279 Issuance of common stock - restricted shares, net of forfeited shares 682 7 (7 ) — — — — Stock-based compensation expense — — 4,652 — — — 4,652 Issuance of stock for 401(k) match 80 1 623 — — — 624 Issuance of common stock for contingent consideration 400 4 3,088 — — — 3,092 Issuance of common stock - equity offering 6,210 62 65,165 — — — 65,227 Cumulative translation adjustment — — — — 11 — 11 Net loss — — — — — (11,111 ) (11,111 ) Balance at March 31, 2024 37,343 $ 373 $ 1,212,913 $ (3,639 ) $ 1,582 $ (1,066,658 ) $ 144,571 The accompanying notes are an integral part of the consolidated financial statements. 38 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) Fiscal Year Ended March 31, 2024 2023 Cash flows from operating activities: Net loss $ (11,111 ) $ (35,041 ) Adjustments to reconcile net loss to net cash used in operations: Depreciation and amortization 4,494 5,361 Stock-based compensation expense 4,652 4,729 Provision for excess and obsolete inventory 1,970 1,467 Deferred income taxes 65 24 Change in fair value of contingent consideration 4,922 70 China dissolution — 1,921 Other non-cash items 44 600 Unrealized foreign exchange gain on cash and cash equivalents (2 ) (226 ) Changes in operating asset and liability accounts: Accounts receivable 4,340 (10,360 ) Inventory (6,841 ) (14,796 ) Prepaid expenses and other current assets 6,313 (5,757 ) Accounts payable and accrued expenses (13,825 ) 8,660 Deferred revenue 7,117 20,863 Net cash provided by (used in) operating activities 2,138 (22,485 ) Cash flows from investing activities: Purchases of property, plant and equipment (934 ) (1,236 ) Change in other assets (27 ) (281 ) Net cash used in investing activities (961 ) (1,517 ) Cash flows from financing activities: Repayment of debt (65 ) (73 ) Proceeds from public equity offering, net 65,227 — Proceeds from exercise of ESPP 279 235 Net cash provided by financing activities 65,441 162 Effect of exchange rate changes on cash, cash equivalents and restricted cash (13 ) 29 Net increase (decrease) in cash, cash equivalents and restricted cash 66,605 (23,811 ) Cash, cash equivalents and restricted cash at beginning of year 25,675 49,486 Cash, cash equivalents and restricted cash at end of year $ 92,280 $ 25,675 Supplemental schedule of cash flow information: Cash paid for income taxes, net of refunds $ 286 $ 350 Non-cash investing and financing activities Issuance of common stock to settle contingent consideration $ 3,092 $ — Issuance of common stock to settle liabilities $ 624 $ 623 The accompanying notes are an integral part of the consolidated financial statements. 39 1.
Biggest changeFINANCIAL STATEMENTS CONSOLIDATED BALANCE SHEETS (In thousands) March 31, March 31, 2025 2024 ASSETS Current assets: Cash and cash equivalents $ 79,494 $ 90,522 Accounts receivable, net 46,186 26,325 Inventory, net 71,169 41,857 Prepaid expenses and other current assets 8,055 7,295 Restricted cash 1,613 468 Total current assets 206,517 166,467 Property, plant and equipment, net 38,572 10,861 Intangibles, net 5,916 6,369 Right-of-use assets 3,829 2,557 Goodwill 48,164 43,471 Restricted cash 4,274 1,290 Deferred tax assets 1,178 1,119 Equity-method investments 1,113 — Other assets 958 637 Total assets $ 310,521 $ 232,771 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 32,282 $ 24,235 Lease liability, current portion 685 716 Debt, current portion — 25 Contingent consideration — 3,100 Deferred revenue, current portion 66,797 50,732 Total current liabilities 99,764 78,808 Deferred revenue, long term portion 9,336 7,097 Lease liability, long term portion 2,684 1,968 Deferred tax liabilities 1,595 300 Other liabilities 28 27 Total liabilities 113,407 88,200 Commitments and Contingencies (Note 18) Stockholders' equity: Common stock, $ 0.01 par value, 75,000,000 shares authorized; 39,887,536 and 37,343,812 shares issued and 39,484,185 and 36,946,181 shares outstanding at March 31, 2025 and 2024, respectively 399 373 Additional paid-in capital 1,259,540 1,212,913 Treasury stock, at cost, 403,351 and 397,631 at March 31, 2025 and 2024, respectively (3,765 ) (3,639 ) Accumulated other comprehensive income 1,565 1,582 Accumulated deficit (1,060,625 ) (1,066,658 ) Total stockholders' equity 197,114 144,571 Total liabilities and stockholders' equity $ 310,521 $ 232,771 The accompanying notes are an integral part of the consolidated financial statements. 49 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) Fiscal Year Ended March 31, 2025 2024 Revenues $ 222,818 $ 145,639 Cost of revenues 160,964 110,356 Gross profit 61,854 35,283 Operating expenses: Research and development 11,425 7,991 Selling, general and administrative 43,091 31,600 Amortization of acquisition related intangibles 1,733 2,152 Change in fair value of contingent consideration 6,682 4,922 Restructuring — (14 ) Total operating expenses 62,931 46,651 Operating loss (1,077 ) (11,368 ) Interest income, net 3,708 1,302 Other expense, net (265 ) (736 ) Income (loss) before income tax (benefit) expense 2,366 (10,802 ) Income tax (benefit) expense (3,667 ) 309 Net income (loss) $ 6,033 $ (11,111 ) Net income (loss) per common share Basic $ 0.16 $ (0.37 ) Diluted $ 0.16 $ (0.37 ) Weighted average number of common shares outstanding Basic 36,990 29,825 Diluted 37,718 29,825 The accompanying notes are an integral part of the consolidated financial statements. 50 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (In thousands) Fiscal Year Ended March 31, 2025 2024 Net income (loss) $ 6,033 $ (11,111 ) Other comprehensive gain (loss), net of tax: Foreign currency translation gain (loss) (17 ) 11 Total other comprehensive (loss) gain, net of tax (17 ) 11 Comprehensive income (loss) $ 6,016 $ (11,100 ) The accompanying notes are an integral part of the consolidated financial statements. 51 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (In thousands) Common Stock Accumulated Other Total Number of Shares Par Value Additional Paid-in Capital Treasury Stock Comprehensive Income (Loss) Accumulated Deficit Stockholders' Equity Balance at March 31, 2023 29,937 $ 299 $ 1,139,113 $ (3,639 ) $ 1,571 $ (1,055,547 ) $ 81,797 Issuance of common stock - ESPP 34 — 279 — — — 279 Issuance of common stock - restricted shares, net of forfeited shares 682 7 (7 ) — — — — Stock-based compensation expense — — 4,652 — — — 4,652 Issuance of stock for 401(k) match 80 1 623 — — — 624 Issuance of common stock for contingent consideration 400 4 3,088 — — — 3,092 Issuance of common stock - Equity Offering 6,210 62 65,165 — — — 65,227 Cumulative translation adjustment — — — — 11 — 11 Net loss — — — — — (11,111 ) (11,111 ) Balance at March 31, 2024 37,343 $ 373 $ 1,212,913 $ (3,639 ) $ 1,582 $ (1,066,658 ) $ 144,571 Issuance of common stock - ESPP 18 — 307 — — — 307 Issuance of common stock - restricted shares, net of forfeited shares 889 10 (9 ) — — — 1 Stock-based compensation expense — — 7,794 — — — 7,794 Issuance of stock for 401(k) match 41 — 845 — — — 845 Repurchase of treasury stock — — — (126 ) — — (126 ) Issuance of common stock - NWL acquisition, net of offering expenses 1,297 13 31,189 — — — 31,202 Issuance of common stock to settle contingent consideration 300 3 6,501 — — — 6,504 Cumulative translation adjustment — — — — (17 ) — (17 ) Net income — — — — — 6,033 6,033 Balance at March 31, 2025 39,888 $ 399 $ 1,259,540 $ (3,765 ) $ 1,565 $ (1,060,625 ) $ 197,114 The accompanying notes are an integral part of the consolidated financial statements. 52 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) Fiscal Year Ended March 31, 2025 2024 Cash flows from operating activities: Net income (loss) $ 6,033 $ (11,111 ) Adjustments to reconcile net income (loss) to net cash provided by operations: Depreciation and amortization 5,560 4,494 Stock-based compensation expense 7,794 4,652 Provision for excess and obsolete inventory 1,532 1,970 Amortization of operating lease right-of-use assets 976 321 Deferred income taxes (4,304 ) 65 Earnings from equity method investments 132 — Change in fair value of contingent consideration 6,682 4,922 Other non-cash items (587 ) 44 Unrealized foreign exchange gain on cash and cash equivalents (41 ) (2 ) Changes in operating asset and liability accounts: Accounts receivable (3,213 ) 4,340 Inventory (7,707 ) (6,841 ) Prepaid expenses and other current assets 543 5,992 Operating leases (1,563 ) (327 ) Accounts payable and accrued expenses 3,209 (13,498 ) Deferred revenue 13,239 7,117 Net cash provided by operating activities 28,285 2,138 Cash flows from investing activities: Purchases of property, plant and equipment (2,415 ) (934 ) Cash paid to settle NWL contingent consideration liability (3,278 ) — Cash paid for NWL Acquisition, net of cash acquired (29,577 ) — Change in other assets 64 (27 ) Net cash used in investing activities (35,206 ) (961 ) Cash flows from financing activities: Repurchase of treasury stock (126 ) — Repayment of debt (25 ) (65 ) Cash paid related to registration of common stock shares (148 ) — Proceeds from public equity offering, net — 65,227 Proceeds from exercise of employee stock options and ESPP 307 279 Net cash provided by financing activities 8 65,441 Effect of exchange rate changes on cash, cash equivalents and restricted cash 14 (13 ) Net (decrease) increase in cash, cash equivalents and restricted cash (6,899 ) 66,605 Cash, cash equivalents and restricted cash at beginning of year 92,280 25,675 Cash, cash equivalents and restricted cash at end of year $ 85,381 $ 92,280 Supplemental schedule of cash flow information: Cash paid for income taxes, net of refunds $ 312 $ 286 Non-cash investing and financing activities Issuance of common stock in connection with the purchase of NWL $ 31,350 $ — Issuance of common stock to settle contingent consideration $ 6,504 $ 3,092 Right-of-use assets obtained in exchange for new lease obligations $ 2,247 $ 680 Issuance of common stock to settle 401(k) match liabilities $ 845 $ 624 The accompanying notes are an integral part of the consolidated financial statements. 53 1.
Intangible Assets Intangible assets at March 31, 2024 and 2023 consisted of the following (in thousands): 2024 2023 Gross Amount Accumulated Amortization Net Book Value Gross Amount Accumulated Amortization Net Book Value Estimated Useful Life Backlog 681 (681 ) — 681 (675 ) 6 2 Trade names and trademarks 1,800 — 1,800 1,800 — 1,800 Indefinite Customer relationships 9,600 (6,649 ) 2,951 9,600 (4,980 ) 4,620 7 Core technology and know-how 5,970 (4,352 ) 1,618 5,970 (3,869 ) 2,101 5-10 Intangible assets $ 18,051 $ (11,682 ) $ 6,369 $ 18,051 $ (9,524 ) $ 8,527 The Company recorded intangible amortization expense of $2.2 million and $2.8 million, for the fiscal years ended March 31, 2024 and 2023 , respectively.
Intangible Assets Intangible assets at March 31, 2025 and 2024 consisted of the following (in thousands): 2025 2024 Gross Amount Accumulated Amortization Net Book Value Gross Amount Accumulated Amortization Net Book Value Estimated Useful Life Backlog 1,381 (1,381 ) — 681 (681 ) - 2 Trade names and trademarks 1,800 — 1,800 1,800 — 1,800 Indefinite Customer relationships 10,880 (7,901 ) 2,980 9,600 (6,649 ) 2,951 7 - 10 Core technology and know-how 5,970 (4,834 ) 1,136 5,970 (4,352 ) 1,618 5-10 Intangible assets $ 20,031 $ (14,116 ) $ 5,916 $ 18,051 $ (11,682 ) $ 6,369 The Company recorded intangible amortization expense of $2.4 million and $2.2 million, for the fiscal years ended March 31, 2025 and 2024 , respectively.
Changes in the Company’s contract assets, which are included in “Unbilled accounts receivable” and “De ferred program costs” (see Note 6, “Accounts Receivable” and Note 7, “Inventory” for a reconciliation to the consolidated balance sheets) and "Contract liabilities", which are included in the current portion and long term portion of “Deferred revenue” in the Company’s consolidated balance sheets, are as follows (in thousands): Unbilled AR Deferred Program Costs Contract Liabilities Ending balance as of March 31, 2023 $ 9,958 $ 2,136 $ 50,760 Increases for costs incurred to fulfill performance obligations — 4,411 — Increase (decrease) due to customer billings (20,392 ) — 77,685 Decrease due to cost recognition on completed performance obligations — (4,021 ) — Increase (decrease) due to recognition of revenue based on transfer of control of performance obligations 16,572 — (70,529 ) Other changes and foreign currency exchange impact 12 (3 ) (87 ) Ending balance as of March 31, 2024 $ 6,150 $ 2,523 $ 57,829 Unbilled AR Deferred Program Costs Contract Liabilities Beginning balance as of March 31, 2022 $ 6,492 $ 858 $ 30,034 Increases for costs incurred to fulfill performance obligations — 2,476 — Increase (decrease) due to customer billings (14,373 ) — 77,489 Decrease due to cost recognition on completed performance obligations — (1,189 ) — Increase (decrease) due to recognition of revenue based on transfer of control of performance obligations 17,839 — (56,643 ) Other changes and foreign currency exchange impact — (9 ) (120 ) Ending balance as of March 31, 2023 $ 9,958 $ 2,136 $ 50,760 The Company’s remaining performance obligations represent the unrecognized revenue value of the Company’s contractual commitments.
Changes in the Company’s contract assets, which are included in “Unbilled accounts receivable” and “De ferred program costs” (see Note 7, “Accounts Receivable” and Note 8, “Inventory” for a reconciliation to the consolidated balance sheets) and "Contract liabilities", which are included in the current portion and long term portion of “Deferred revenue” in the Company’s consolidated balance sheets, are as follows (in thousands): Unbilled AR Deferred Program Costs Contract Liabilities Beginning balance as of March 31, 2024 $ 6,150 $ 2,523 $ 57,829 Increases for balances acquired — — 5,049 Increases for costs incurred to fulfill performance obligations — 16,363 — Increase (decrease) due to customer billings (8,754 ) — 120,533 Decrease due to cost recognition on completed performance obligations — (13,131 ) — Increase (decrease) due to recognition of revenue based on transfer of control of performance obligations 8,981 — (107,211 ) Other changes and foreign currency exchange impact (1 ) 1 (67 ) Ending balance as of March 31, 2025 $ 6,376 $ 5,756 $ 76,133 Unbilled AR Deferred Program Costs Contract Liabilities Beginning balance as of March 31, 2023 $ 9,958 $ 2,136 $ 50,760 Increases for costs incurred to fulfill performance obligations — 4,411 — Increase (decrease) due to customer billings (20,392 ) — 77,685 Decrease due to cost recognition on completed performance obligations — (4,021 ) — Increase (decrease) due to recognition of revenue based on transfer of control of performance obligations 16,572 — (70,529 ) Other changes and foreign currency exchange impact 12 (3 ) (87 ) Ending balance as of March 31, 2024 $ 6,150 $ 2,523 $ 57,829 68 The Company’s remaining performance obligations represent the unrecognized revenue value of the Company’s contractual commitments.
The following table summarizes stock-based compensation expense by financial statement line item for the fiscal years ended March 31, 2024 and 2023 (in thousands): Fiscal years ended March 31, 2024 2023 Cost of revenues $ 293 $ 283 Research and development 627 865 Selling, general and administrative 3,732 3,581 Total $ 4,652 $ 4,729 59 The following table summarizes the information concerning currently outstanding and exercisable employee and non-employee options: Options / Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value (thousands) Outstanding at March 31, 2023 81,205 $ 16.92 Granted — — Exercised — — Canceled/forfeited (44,999 ) 24.95 Outstanding at March 31, 2024 36,206 $ 6.94 6.2 $ 238 Exercisable at March 31, 2024 25,924 $ 7.34 5.4 $ 160 Fully vested and expected to vest at March 31, 2024 36,107 $ 6.94 6.2 $ 237 The Company did not grant any stock options under the 2007 Director Plan nor under the 2022 Plan during the fiscal year ended March 31, 2024 .
The following table summarizes stock-based compensation expense by financial statement line item for the fiscal years ended March 31, 2025 and 2024 (in thousands): Fiscal years ended March 31, 2025 2024 Cost of revenues $ 536 $ 293 Research and development 1,132 627 Selling, general and administrative 6,126 3,732 Total $ 7,794 $ 4,652 The following table summarizes the information concerning currently outstanding and exercisable employee and non-employee options: Options / Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value (thousands) Outstanding at March 31, 2024 36,206 $ 6.94 Granted — Exercised — Canceled/forfeited — Outstanding at March 31, 2025 36,206 $ 6.94 5.2 $ 406 Exercisable at March 31, 2025 36,206 $ 6.94 5.2 $ 406 Fully vested and expected to vest at March 31, 2025 36,206 $ 6.94 5.2 $ 406 81 The Company did not grant any stock options under the 2007 Director Plan nor the 2022 Plan during both fiscal years ended March 31, 2025 and 2024 .
Accounts Payable and Accrued Expenses Accounts payable and accrued expenses at March 31, 2024 and March 31, 2023 consisted of the following (in thousands): March 31, 2024 March 31, 2023 Accounts payable $ 4,476 $ 13,935 Accrued inventories in-transit 539 2,267 Accrued other miscellaneous expenses 2,366 2,662 Accrued contract loss 97 3,464 Advanced deposits 2,270 5,653 Accrued compensation 10,326 5,430 Income taxes payable 346 409 Accrued product warranty 2,363 2,638 Accrued commissions 1,452 1,208 Accrued restructuring — 717 Total $ 24,235 $ 38,383 The Company generally provides a one to three year warranty on its products, commencing upon delivery or installation, where applicable.
Accounts Payable and Accrued Expenses Accounts payable and accrued expenses at March 31, 2025 and March 31, 2024 consisted of the following (in thousands): March 31, 2025 March 31, 2024 Accounts payable $ 6,733 $ 4,476 Accrued inventories in-transit 2,111 539 Accrued other miscellaneous expenses 3,600 2,366 Accrued contract loss 97 97 Advanced deposits 1,267 2,270 Accrued compensation 13,418 10,326 Income taxes payable 305 346 Accrued product warranty 3,033 2,363 Accrued commissions 1,718 1,452 Total $ 32,282 $ 24,235 The Company generally provides a one to three year warranty on its products, commencing upon delivery or installation where applicable.
Inventory Inventory, net of reserves, at March 31, 2024 and March 31, 2023 consisted of the following (in thousands): March 31, 2024 March 31, 2023 Raw materials $ 20,622 $ 16,654 Work-in-process 14,872 15,200 Finished goods 3,840 2,996 Deferred program costs 2,523 2,136 Inventory $ 41,857 $ 36,986 The Company recorded inventory write-downs of $2.0 million and $1.5 million for the fiscal years ended March 31, 2024 and 2023 , respectively.
Inventory Inventory, net of reserves, at March 31, 2025 and March 31, 2024 consisted of the following (in thousands): March 31, 2025 March 31, 2024 Raw materials $ 35,892 $ 20,622 Work-in-process 19,633 14,872 Finished goods 9,888 3,840 Deferred program costs 5,756 2,523 Inventory $ 71,169 $ 41,857 The Company recorded inventory write-downs of $1.5 million and $2.0 million for the fiscal years ended March 31, 2025 and 2024 , respectively.